Winston Salem, NC – According to filings with the U.S. Securities and Exchange Commission, Javara is raising $7,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jennifer Byrne played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Javara
Javara Inc., is an Integrated Research Organization accelerating the clinical trial process through engaging healthcare partners in conducting industry sponsored clinical trials. Bridging population health strategies to clinical research as a care option. Javaras commitment: 30 days or less from award to activation. Contact us to learn how we can execute your clinical trials.

To learn more about Javara, visit http://www.javararesearch.com/

Contact:
Jennifer Byrne, Chief Executive Officer
336-365-0538
jbyrne@javararesearch.com
https://www.linkedin.com/in/jenniferjbyrne/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved